PPD Raises $1.6 Billion in IPO

PPD Inc, the drug research and biotech company, raised more than $1.6 billion in its initial public offering. Its 60 million shares were sold for 27 dollars each, after an original listing range of $24-$27.

The North Carolina-based PPD has had a profitable run the past year. For the nine months ended September 30, PPD’s revenue was $2.98 billion, with a net income of $34 million.

The stock is set to trade on the Nasdaq. Barclays Plc, JPMorgan Chase & Co., Morgan Stanley, and Goldman Sachs Group Inc were the underwriters for the stocks.

The underwriters will get an option of an additional 9 million shares to cover overallotments, PPD said.

This is the largest IPO listing in the US so far. PPD’s IPO is bigger than the $1.23 billion made by Reynolds Consumer Products Inc., recently.

The bourses are a true test of a companies performance, and PPD seems to have done better than some of the tech Unicorns’ IPOs recently. Uber and Lyft both are trading much below their offering price.

 Market analysts say that B2B companies are faring better than B2C companies in their initial offerings.

PPD IPO

PPD is a global contract research organization and is into drug development, laboratory, and lifecycle management services. It provides technical and therapeutic expertise in developing affordable life-changing drugs.

Kathleen Smith, co-founder, and chairwoman of data-focused exchange-traded fund issuer Renaissance Capital, said in a statement, “PPD provides investors with a safe way to play biotechs because they do all the research studies for the biotech industry. It’s a 25% top-line grower. It’s a profitable company. It’s got a very strong business. We think that there’ll be others like this.”

The company says that the market size of its clinical and research services exceeds $50 billion, with projected market growth rates in the range of 5% to 9%.

PPD has conducted more than 2,100 clinical trials, and its laboratory scientists have completed more than 57,000 pharmaceutical development projects and worked with more than 7,600 compounds, according to its filings.

PPD Inc. was acquired by private equity firms Carlyle Group and Hellman & Friedman in 2011 for $4 billion.

In a renewed recapitalization in 2017, it achieved a valuation of $9 billion.

PPD major investors are Hellman & Friedman, The Carlyle Group, Blue Spectrum Investor, GIC (Singapore), ADIA (Abu Dhabi).

PPD has a heavy debt load, $8.2 billion as of September 30, 2019. The interest rate on this debt runs to $305 million per year, eliminating 75% of its operating profits.

In its filing, the company has said that the money raised will be used to pay off some of its debts.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Evergrande: A black swan event that could spook markets

Evergrande: A black swan event that could spook markets

EverGrande is now known as the “world’s most indebted property developer” and serves as a symbol of corporate excess.
19 hours ago
Moderna vaccine more effective than Pfizer, study says

Moderna vaccine more effective than Pfizer, study says

Moderna’s Covid-19 vaccine does a slightly better job of preventing coronavirus-related hospitalizations and emergency department visits.
3 days ago
iPhone 13 and iPhone 13 Pro: Specifications, Release Date, Features and much more

iPhone 13 and iPhone 13 Pro: Specifications, Release Date, Features and much more

Apple iPhone 13 Pro and iPhone 13 Pro Max can be a hit with its ever new technology A15 Bionic chip and other cool profound features.
4 days ago
Total signs $27 billion energy deal to fund 1-gigawatt solar power plant

Total signs $27 billion energy deal to fund 1-gigawatt solar power plant

The French oil major, Total, has signed a $27 billion deal to fund a 1-gigawatt solar power plant, and boost oil and gas production in the Middle-East region.
4 days ago
PMI seals $1.51 billion takeover of British inhalation specialist Vectura

PMI seals $1.51 billion takeover of British inhalation specialist Vectura

Philip Morris International (PMI) acquires a 22.6% stake in British inhalation specialist Vecutra closing in on the controversial $1.51 billion takeover.
5 days ago
Apple co-founder Steve Wozniak joins the space race

Apple co-founder Steve Wozniak joins the space race

Wozniak, popularly known as “Woz”, is setting up a private space company with Ripcord co-founder Alex Fielding. In a tweet, Wozniak shared a promotional video for the company c
6 days ago